☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Aquestive
Aquestive Entered into a License, Development & Supply Agreement with Haisco to Develop and Commercialize Exservan (riluzole oral...
March 4, 2022
MTPA and Aquestive Sign a License and Supply Agreement for Exservan (riluzole) to Treat ALS in the US
January 22, 2021
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)
January 22, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
